CD8 Antibody, anti-human, pure, REAfinity™ | Miltenyi Biotec 130-122-281 product information

This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.

product summary

company name :

Miltenyi Biotec

product type :

antibody

product name :

CD8 Antibody, anti-human, pure, REAfinity™

catalog :

130-122-281

quantity :

100 µg in 100 µL

price :

205 USD

clonality :

monoclonal

host :

human

conjugate :

nonconjugated

clone name :

REA734

reactivity :

human

application :

mass cytometry

citations: 2

Reference
Wullenkord R, Reicherts C, Mikesch J, Marx J, Wethmar K, Albring J, et al. Sequential therapy with inotuzumab ozogamicin, CD19 CAR T cells, and blinatumomab in an elderly patient with relapsed acute lymphoblastic leukemia. Ann Hematol. 2021;100:587-589 pubmed publisher
Gao G, Jakobsen B. Molecular interactions of coreceptor CD8 and MHC class I: the molecular basis for functional coordination with the T-cell receptor. Immunol Today. 2000;21:630-6 pubmed

product information

MB Cataloge Number :

130-122-281

Catalog Number :

130-122-281

Product Name :

CD8 Antibody, anti-human, pure, REAfinity™

Product Type :

Primary antibodies, Recombinant antibodies

Host Species :

recombinant human IgG1

Clonality :

monoclonal

Conjugation :

pure

Antigen Modification :

CD8

Clone Name :

REA734

Isotype :

REA Control Antibody (S), human IgG1

Size :

100 µg in 100 µL

US List Price :

205 USD

Product Description :

Identification and enumeration of CD8+ cells by mass cytometry

ALTnames :

Leu-2, CD8a, MAL, p32, Cd8b1, LY3, Lyt3, P37, Ly-2

Specificity :

human

Uses :

For research use only

Application Summary :

Mass cytometry

Storage :

Store protected from light at 2–8 °C. Do not freeze.